Humoral and cellular responses after third dose of SARS-CoV-2 vaccine in myeloproliferative neoplasms patients on ruxolitinib therapy.
Atanasio A, Vanni A, Maggi L, Pilerci S, Mazzoni A, Capone M, Crupi F, Cicogna P, Boldrini V, Tekle S, Colao MG, Borella M, Paoli C, Rossolini GM, Vannucchi AM, Annunziato F, Guglielmelli P.
Atanasio A, et al. Among authors: tekle s.
Leuk Res. 2023 Aug;131:107330. doi: 10.1016/j.leukres.2023.107330. Epub 2023 May 29.
Leuk Res. 2023.
PMID: 37269750
Free PMC article.
No abstract available.